Cargando…
Novel galenic formulations for delivering immunochemotherapies: kill intelligently, remove the checkpoint and let the T cells in!
Autores principales: | Kepp, Oliver, Kroemer, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678943/ https://www.ncbi.nlm.nih.gov/pubmed/33244441 http://dx.doi.org/10.1080/2162402X.2020.1846358 |
Ejemplares similares
-
Current trends of anticancer immunochemotherapy
por: Vacchelli, Erika, et al.
Publicado: (2013) -
A novel platinum-based chemotherapeutic inducing immunogenic cell death
por: Kepp, Oliver, et al.
Publicado: (2020) -
Small cell lung cancer responds to immunogenic chemotherapy followed by PD-1 blockade
por: Kroemer, Guido, et al.
Publicado: (2021) -
Radiochemotherapy-induced elevations of plasma HMGB1 levels predict therapeutic responses in cancer patients
por: Kroemer, Guido, et al.
Publicado: (2021) -
A mitochondrial checkpoint to adaptive anticancer immunity
por: Kepp, Oliver, et al.
Publicado: (2023)